Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 21149253)

1.

Risk factors for oligodendroglial tumors: a pooled international study.

McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H, Feychting M, Il'yasova D, Inskip PD, Johansen C, Melin BS, Ruder AM, Butler MA, Scheurer ME, Schüz J, Schwartzbaum JA, Wrensch MR, Davis FG.

Neuro Oncol. 2011 Feb;13(2):242-50. doi: 10.1093/neuonc/noq173. Epub 2010 Dec 10.

2.

SWI/SNF gene variants and glioma risk and outcome.

Amankwah EK, Thompson RC, Nabors LB, Olson JJ, Browning JE, Madden MH, Egan KM.

Cancer Epidemiol. 2013 Apr;37(2):162-5. doi: 10.1016/j.canep.2012.12.001. Epub 2012 Dec 29.

3.

Classification of oligodendroglial tumors based on histopathology criteria is a significant predictor of survival--clinical, radiological and pathologic long-term follow-up analysis.

Sepulveda Sanchez JM, Martinez Montero JC, Diez-Lobato R, Hernandez-Lain A, Cabello A, Ramos A, Gonzalez Leon P, Ricoy Campo JR.

Clin Neuropathol. 2009 Jan-Feb;28(1):11-20. Erratum in: Clin Neuropathol. 2009 Mar-Apr;28(2):150.

PMID:
19216215
4.

The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.

Smith SF, Simpson JM, Brewer JA, Sekhon LH, Biggs MT, Cook RJ, Little NS.

J Neurooncol. 2006 Oct;80(1):75-82. Epub 2006 Jun 23.

PMID:
16794749
5.

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

Kouwenhoven MC, Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van Duinen SG, Teepen JL, Wesseling P, Vandenbos F, Grisold W, Sipos L, Mirimanoff R, Vecht CJ, Allgeier A, Lacombe D, van den Bent MJ.

Neuro Oncol. 2009 Dec;11(6):737-46. doi: 10.1215/15228517-2009-011. Epub .

6.

Incidence of and survival from oligodendroglioma in Denmark, 1943-2002.

Nielsen MS, Christensen HC, Kosteljanetz M, Johansen C.

Neuro Oncol. 2009 Jun;11(3):311-7. doi: 10.1215/15228517-2008-105. Epub 2008 Dec 9.

7.

Time trends in oligodendroglial and astrocytic tumor incidence.

McCarthy BJ, Propp JM, Davis FG, Burger PC.

Neuroepidemiology. 2008;30(1):34-44. doi: 10.1159/000115440. Epub 2008 Feb 6.

PMID:
18259099
8.

Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas.

Bauman GS, Cairncross JG.

Semin Radiat Oncol. 2001 Apr;11(2):170-80. Review.

PMID:
11285555
9.

Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.

Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G.

Brain Pathol. 2004 Apr;14(2):121-30.

PMID:
15193024
11.

History of allergies and autoimmune diseases and risk of brain tumors in adults.

Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Int J Cancer. 2002 May 10;99(2):252-9.

PMID:
11979441
12.

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

Panageas KS, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Roldán Urgoiti GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, Deangelis LM, Jhanwar SC, Rosenblum MK, Lassman AB.

Neuro Oncol. 2012 Jun;14(6):761-7. doi: 10.1093/neuonc/nos065. Epub 2012 May 31.

13.

Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.

Emblem KE, Scheie D, Due-Tonnessen P, Nedregaard B, Nome T, Hald JK, Beiske K, Meling TR, Bjornerud A.

AJNR Am J Neuroradiol. 2008 Oct;29(9):1664-70. doi: 10.3174/ajnr.A1182. Epub 2008 Jun 26.

14.

Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.

Scheie D, Meling TR, Cvancarova M, Skullerud K, Mørk S, Lote K, Eide TJ, Helseth E, Beiske K.

Neuro Oncol. 2011 Nov;13(11):1225-33. doi: 10.1093/neuonc/nor114. Epub 2011 Aug 19.

15.

Clinicopathological study of oligodendroglial tumors: the effectiveness of interferon beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors.

Wakabayashi T, Kajita Y, Hatano N, Thompson T, Nagasaka T, Yoshida J.

Brain Tumor Pathol. 2000;17(1):29-33.

PMID:
10982007
16.

Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls.

Il'yasova D, McCarthy B, Marcello J, Schildkraut JM, Moorman PG, Krishnamachari B, Ali-Osman F, Bigner DD, Davis F.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1232-8. doi: 10.1158/1055-9965.EPI-08-0995. Epub 2009 Mar 31.

17.

Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.

Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.

Clin Cancer Res. 2002 Jan;8(1):196-201.

18.

Use of statins and risk of glioma: a nationwide case-control study in Denmark.

Gaist D, Andersen L, Hallas J, Sørensen HT, Schrøder HD, Friis S.

Br J Cancer. 2013 Feb 19;108(3):715-20. doi: 10.1038/bjc.2012.536. Epub 2013 Jan 15.

19.

Leptomeningeal disease in oligodendroglial tumors: a population-based study.

Roldán G, Chan J, Eliasziw M, Cairncross JG, Forsyth PA.

J Neurooncol. 2011 Sep;104(3):811-5. doi: 10.1007/s11060-011-0551-3. Epub 2011 Mar 4.

20.

Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors.

Trost D, Ehrler M, Fimmers R, Felsberg J, Sabel MC, Kirsch L, Schramm J, Wiestler OD, Reifenberger G, Weber RG.

Int J Cancer. 2007 Jun 1;120(11):2368-76.

PMID:
17285580
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk